scholarly journals Aminated Graphene Oxide as a Potential New Therapy for Colorectal Cancer

2019 ◽  
Vol 2019 ◽  
pp. 1-15 ◽  
Author(s):  
Natalia Krasteva ◽  
Milena Keremidarska-Markova ◽  
Kamelia Hristova-Panusheva ◽  
Tonya Andreeva ◽  
Giorgio Speranza ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Graphene Oxide ◽  
Cancer Therapy ◽  
Cancer Cells ◽  
Cellular Proliferation ◽  
Drug Carriers ◽  
Delivery Systems ◽  
Cellular Systems ◽  
Functionalized Graphene Oxide ◽  
The Impact

Nanotechnology-based drug delivery systems for cancer therapy are the topic of interest for many researchers and scientists. Graphene oxide (GO) and its derivates are among the most extensively studied delivery systems of this type. The increased surface area, elevated loading capacity, and aptitude for surface functionalization together with the ability to induce reactive oxygen species make GO a promising tool for the development of novel anticancer therapies. Moreover, GO nanoparticles not only function as effective drug carriers but also have the potential to exert their own inhibitory effects on tumour cells. Recent results show that the functionalization of GO with different functional groups, namely, with amine groups, leads to increased reactivity of the nanoparticles. The last steers different hypotheses for the mechanisms through which this functionalization of GO could potentially lead to improved anticancer capacity. In this research, we have evaluated the potential of amine-functionalized graphene oxide nanoparticles (GO-NH2) as new molecules for colorectal cancer therapy. For the purpose, we have assessed the impact of aminated graphene oxide (GO) sheets on the viability of colon cancer cells, their potential to generate ROS, and their potential to influence cellular proliferation and survival. In order to elucidate their mechanism of action on the cellular systems, we have probed their genotoxic and cytostatic properties and compared them to pristine GO. Our results revealed that both GO samples (pristine and aminated) were composed of few-layer sheets with different particle sizes, zeta potential, and surface characteristics. Furthermore, we have detected increased cyto- and genotoxicity of the aminated GO nanoparticles following 24-hour exposure on Colon 26 cells. The last leads us to conclude that exposure of cancer cells to GO, namely, aminated GO, can significantly contribute to cancer cell killing by enhancing the cytotoxicity effect exerted through the induction of ROS, subsequent DNA damage, and apoptosis.

Hyaluronan based Multifunctional Nano-carriers for Combination Cancer Therapy

2020 ◽  
Vol 20 ◽  
Author(s):  
Menghan Gao ◽  
Hong Deng ◽  
Weiqi Zhang
Keyword(s):  
Cancer Therapy ◽  
Combination Therapy ◽  
Cancer Cells ◽  
Drug Loading ◽  
Tumor Therapy ◽  
Drug Carriers ◽  
Functional Sites ◽  
Therapeutic Modalities ◽  
Combination Cancer Therapy ◽  
Targeting Strategy

: Hyaluronan (HA) is a natural linear polysaccharide that has excellent hydrophilicity, biocompatibility, biodegradability, and low immunogenicity, making it one of the most attractive biopolymers used for biomedical researches and applications. Due to the multiple functional sites on HA and its intrinsic affinity for CD44, a receptor highly expressed on various cancer cells, HA has been widely engineered to construct different drug-loading nanoparticles (NPs) for CD44- targeted anti-tumor therapy. When a cocktail of drugs is co-loaded in HA NP, a multifunctional nano-carriers could be obtained, which features as a highly effective and self-targeting strategy to combat the cancers with CD44 overexpression. The HA-based multidrug nano-carriers can be a combination of different drugs, various therapeutic modalities, or the integration of therapy and diagnostics (theranostics). Up to now, there are many types of HA-based multidrug nano-carriers constructed by different formulation strategies including drug co-conjugates, micelles, nano-gels and hybrid NP of HA and so on. This multidrug nano-carrier takes the full advantages of HA as NP matrix, drug carriers and targeting ligand, representing a simplified and biocompatible platform to realize the targeted and synergistic combination therapy against the cancers. In this review, recent progresses about HA-based multidrug nano-carriers for combination cancer therapy are summarized and its potential challenges for translational applications have been discussed.

Biocompatible hole scavenger–assisted graphene oxide dots for photodynamic cancer therapy

Nanoscale ◽  
2021 ◽  
Author(s):  
Chun-Yan Shih ◽  
Wei-Lun Huang ◽  
I-Ting Chiang ◽  
Wu-Chou Su ◽  
Hsisheng Teng
Keyword(s):  
Ascorbic Acid ◽  
Graphene Oxide ◽  
Cancer Therapy ◽  
Cancer Cells ◽  
Nitrogen Doped ◽  
Photodynamic Cancer Therapy ◽  
Hole Scavenger ◽  
Nitrogen Doped Graphene ◽  
Doped Graphene

Tuning of the nitrogen-doped graphene oxide dot and ascorbic acid concentrations can selectively kill cancer cells through either apoptosis or necrosis.

COMPUTATIONAL MODELING OF EPOXY-BASED HYBRID COMPOSITES REINFORCED WITH CARBON FIBERS AND FUNCTIONALIZED GRAPHENE NANOPLATELETS

2021 ◽  
Author(s):  
HASHIM AL MAHMUD ◽  
, MATTHEW RADUE ◽  
WILLIAM PISANI ◽  
GREGORY ODEGARD
Keyword(s):  
Mechanical Properties ◽  
Graphene Oxide ◽  
Hybrid Composites ◽  
Graphene Nanoplatelets ◽  
Pristine Graphene ◽  
Functionalized Graphene ◽  
Functionalized Graphene Oxide ◽  
Aspect Ratios ◽  
The Impact ◽  
Nanoscale Level

The impact on the mechanical properties of unidirectional carbon fiber (CF)/epoxy composites reinforced with pristine graphene nanoplatelets (GNP), highly concentrated graphene oxide (GO), and Functionalized Graphene Oxide (FGO) are investigated in this study. The localized reinforcing effect of each of the graphene nanoplatelet types on the epoxy matrix is predicted at the nanoscale-level by molecular dynamics. The bulk-level mechanical properties of unidirectional CF/epoxy hybrid composites are predicted using micromechanics techniques considering the reinforcing function, content, and aspect ratios for each of the graphene nanoplatelets. In addition, the effect of nanoplatelets dispersion level is also investigated for the pristine graphene nanoplatelets considering a lower dispersion level with four layers of graphene nanoplatelets (4GNP). The results indicate that the shear and transverse properties are significantly affected by the nanoplatelet type, loading and aspect ratio. The results of this study can be used in the design of hybrid composites to tailor specific laminate properties by adjusting nanoplatelet parameters.

scholarly journals Bioactivity of PEGylated Graphene Oxide Nanoparticles Combined with Near-Infrared Laser Irradiation Studied in Colorectal Carcinoma Cells

Nanomaterials ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 3061
Author(s):  
Natalia Krasteva ◽  
Dessislava Staneva ◽  
Bela Vasileva ◽  
George Miloshev ◽  
Milena Georgieva
Keyword(s):  
Colorectal Cancer ◽  
Graphene Oxide ◽  
Colorectal Carcinoma ◽  
Cancer Cells ◽  
Laser Irradiation ◽  
Molecular Mechanisms ◽  
Near Infrared ◽  
Carcinoma Cells ◽  
Infrared Light ◽  
Mitochondrial Activity

Central focus in modern anticancer nanosystems is given to certain types of nanomaterials such as graphene oxide (GO). Its functionalization with polyethylene glycol (PEG) demonstrates high delivery efficiency and controllable release of proteins, bioimaging agents, chemotherapeutics and anticancer drugs. GO–PEG has a good biological safety profile, exhibits high NIR absorbance and capacity in photothermal treatment. To investigate the bioactivity of PEGylated GO NPs in combination with NIR irradiation on colorectal cancer cells we conducted experiments that aim to reveal the molecular mechanisms of action of this nanocarrier, combined with near-infrared light (NIR) on the high invasive Colon26 and the low invasive HT29 colon cancer cell lines. During reaching cancer cells the phototoxicity of GO–PEG is modulated by NIR laser irradiation. We observed that PEGylation of GO nanoparticles has well-pronounced biocompatibility toward colorectal carcinoma cells, besides their different malignant potential and treatment times. This biocompatibility is potentiated when GO–PEG treatment is combined with NIR irradiation, especially for cells cultured and treated for 24 h. The tested bioactivity of GO–PEG in combination with NIR irradiation induced little to no damages in DNA and did not influence the mitochondrial activity. Our findings demonstrate the potential of GO–PEG-based photoactivity as a nanosystem for colorectal cancer treatment.

The role of butyrate in surgical and oncological outcomes in colorectal cancer

2021 ◽  
Author(s):  
Roy Hajjar ◽  
Carole S Richard ◽  
Manuela M Santos
Keyword(s):  
Colorectal Cancer ◽  
Cancer Cells ◽  
Current Knowledge ◽  
Intestinal Barrier ◽  
Inhibitory Effect ◽  
Intestinal Barrier Function ◽  
Current Evidence ◽  
Mucus Production ◽  
Antineoplastic Effect ◽  
The Impact

Butyrate is a short-chain fatty acid produced by colonic gut bacteria as a result of fermentation of dietary fibers. In the colon, butyrate is a major energy substrate and contributes to the nutritional support and proliferation of a healthy mucosa. It also promotes the intestinal barrier function by enhancing mucus production and tight junctions. In addition to its pro-proliferative effect in healthy colonocytes, butyrate inhibits the proliferation of cancer cells. The antineoplastic effect of butyrate is associated with the inhibitory effect of butyrate on histone deacetylase (HDAC) enzymes, which promote carcinogenesis. Due to the metabolic shift of cancer cells toward glycolysis, unused butyrate accumulates and inhibits procarcinogenic HDACs. In addition, recent studies suggest that butyrate may improve the healing of colonic tissue after surgery in animal models, specifically at the site of reconnection of colonic ends - anastomosis - after surgical resection. Here, we review current evidence on the impact of butyrate on epithelial integrity and colorectal cancer and present current knowledge on data that support its potential applications in surgical practice.

Combination of TNF-α and graphene oxide-loaded BEZ235 to enhance apoptosis of PIK3CA mutant colorectal cancer cells

2013 ◽  
Vol 1 (41) ◽  
pp. 5602 ◽  
Author(s):  
Yuhua Cao ◽  
Yu Chong ◽  
He Shen ◽  
Mengxin Zhang ◽  
Jie Huang ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Graphene Oxide ◽  
Cancer Cells ◽  
Tnf Α ◽  
Colorectal Cancer Cells

Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells

2016 ◽  
Vol 147 ◽  
pp. 315-325 ◽  
Author(s):  
Rana Imani ◽  
Wei Shao ◽  
Samira Taherkhani ◽  
Shahriar Hojjati Emami ◽  
Satya Prakash ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Graphene Oxide ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Sirna Delivery ◽  
Functionalized Graphene ◽  
Functionalized Graphene Oxide
Sign in / Sign up

Export Citation Format

Share Document